Search

everythinglearnresearchcommunity

for

Search:↓

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

Tofacitinib may help regrow hair in alopecia areata patients.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Baricitinib helps regrow hair and improves quality of life and mental health in severe alopecia areata patients.

Abatacept may help some people with alopecia areata regrow hair.

Allopregnanolone changes gene expression in glioblastoma cells.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

KeraGLO improves skin and hair health.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

The new delivery system improves treatment for hair loss by enhancing drug absorption and effectiveness.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

IVL3001 is safe, effective, and better than oral finasteride for treating hair loss.

Both steroid treatments effectively regrow hair in severe alopecia areata.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

cp-asiAR may effectively treat hair loss by targeting androgen receptors.

Baricitinib shows promise in treating severe hair loss.

Recombinant Filaggrin-2 microneedles effectively promote hair growth and repair in hair loss.

Injecting alpha-melanocyte-stimulating hormone in mice improved skin healing and reduced scarring.

Thyroid receptor agonists may treat male pattern baldness without harmful side effects.

A woman with advanced eye cancer went into complete remission using a combination of immunotherapy and topical treatments.